KEYNOTE-564: A phase 3, randomized, double blind, trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Choueiri, TK; Quinn, DI; Zhang, T; Gurney, H; Doshi, GK; Cobb, PW; Parnis, F; Lee, J-L; Park, SH; Semenov, A; Chang, WY-H; Wan, SM; Poehlein, CH; Powles, T

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • TPS4599 - TPS4599

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.tps4599